Cite
59 Safety and efficacy of a risk-based obstetric heparin-based thromboprophylaxis regimen
MLA
Mythreyi Mahalingam, et al. “59 Safety and Efficacy of a Risk-Based Obstetric Heparin-Based Thromboprophylaxis Regimen.” American Journal of Obstetrics and Gynecology, vol. 224, Feb. 2021, pp. S41–42. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........179d613591e964454467189273a37974&authtype=sso&custid=ns315887.
APA
Mythreyi Mahalingam, Dhong-Jin Kim, Martha F. Ruzic, Allison J. Lazenby, Michelle Y. Lu, Jeff M. Szychowski, Christina T. Blanchard, Gabriella D. Cozzi, Kacie R. Oglesby, Elle R. Kaplan, Macie L. Champion, Sarah A. Dunk, Margaret R. Page, Akila Subramaniam, Elizabeth B. Ausbeck, Elisa T. Bushman, Brian M. Casey, Alan T.N. Tita, & Rodrigo D.D. Muñoz Rogers. (2021). 59 Safety and efficacy of a risk-based obstetric heparin-based thromboprophylaxis regimen. American Journal of Obstetrics and Gynecology, 224, S41–S42.
Chicago
Mythreyi Mahalingam, Dhong-Jin Kim, Martha F. Ruzic, Allison J. Lazenby, Michelle Y. Lu, Jeff M. Szychowski, Christina T. Blanchard, et al. 2021. “59 Safety and Efficacy of a Risk-Based Obstetric Heparin-Based Thromboprophylaxis Regimen.” American Journal of Obstetrics and Gynecology 224 (February): S41–42. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........179d613591e964454467189273a37974&authtype=sso&custid=ns315887.